Longitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) dementia are characterised by progressive brain atrophy. Longitudinal MRI volumetry may help to characterise ongoing structural degeneration and support the differential diagnosis of dementia subtypes. Automated, observer-independent atlas-based MRI volumetry was applied to analyse 102 MRI data sets from 15 bvFTD, 14 AD, and 10 healthy elderly control participants with consecutive scans over at least 12 months. Anatomically defined targets were chosen a priori as brain structures of interest. Groups were compared regarding volumes at clinic presentation and annual change rates. Baseline volumes, especially of grey matter compartments, were significantly reduced in bvFTD and AD patients. Grey matter volumes of the caudate and the gyrus rectus were significantly smaller in bvFTD than AD. The bvFTD group could be separated from AD on the basis of caudate volume with high accuracy (79% cases correct). Annual volume decline was markedly larger in bvFTD and AD than controls, predominantly in white matter of temporal structures. Decline in grey matter volume of the lateral orbitofrontal gyrus separated bvFTD from AD and controls. Automated longitudinal MRI volumetry discriminates bvFTD from AD. In particular, greater reduction of orbitofrontal grey matter and temporal white matter structures after 12 months is indicative of bvFTD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, machine learning techniques have been applied to distinguish between bvFTD and Cognitively Normal Subjects (CNCs), Alzheimer Disease or other psychiatric and neurologic disorders on an individual level using MRI-based features. 9-17”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In general, they achieved moderate to high accuracy distinguishing bvFTD.”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Frings et al. showed that annual volume decline was larger in bvFTD, then AD, and then in controls, predominantly in white matter of temporal areas and orbitofrontal grey matter [47].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [47]
In the citing paper
“WM volume, as measured with structural MRI, manifested a steeper decline, especially in the temporal lobe, compared to early GM orbitofrontal and insula atrophy (1 year, N = 15) (Frings et al., 2014).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Frings et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 2×
“Univariate tests were followed by correction of the original p-values according to the method of Benjamini and Hochberg [22] using the MATLAB script available at [www.”
MethodMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676 · cited 1×
“Modulation compensates for dilatation or shrinkage during spatial normalization and has the effect of preserving the total amount of signal from the respective tissue class in the normalized partitions [21].”
BackgroundSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 2×
“The revised diagnostic criteria for bvFTD [6] incorporate neuroimaging evidence of frontal and/or temporal brain atrophy changes at presentation.”
BackgroundSelf-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016 · cited 3×
“All participants from the FRONTIER database underwent general cognitive screening using the Addenbrooke’s Cognitive Examination (ACE-R) [17] to determine their overall cognitive functioning.”
MethodInfluentialSelf-citationRevising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“Diagnostic criteria for both have been proposed [2,3] but clinical diagnosis remains challenging [4,5].”
BackgroundLongitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain
Resnick, S. M., Pham, D. L., Kraut, M. A., Zonderman, A. B., & Davatzikos, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03295.2003 · Cited by 1,425 · cited 1×
“Annual volume decrease in the group of healthy elderly controls was ,1% overall which is commensurate with prior estimates [36,37].”
ResultThe Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
The prevalence of frontotemporal dementia
Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002) · Neurology · doi:10.1212/wnl.58.11.1615 · Cited by 1,157 · cited 1×
“Behavioural variant frontotemporal dementia (bvFTD) and Alzheimer’s disease (AD) are the two most prevalent early-onset dementias [1].”
BackgroundSelf-citation
Cited by
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
“…comparing behavioural variant (bv)FTD, AD and healthy controls with consecutive scans over at least 12 months, Frings et al. showed that annual volume decline was larger in bvFTD, then AD, and then in controls, predominantly in white matter of temporal areas and orbitofrontal grey matter [47].”
BackgroundWhite matter degeneration in vascular and other ageing‐related dementias
Hase, Y., Horsburgh, K., Ihara, M., & Kalaria, R. N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14271 · Cited by 208
“WMH are also common in neurodegenerative dementias including Alzheimer’s disease (AD) (Gouw et al. 2008a; Frings et al. 2014; Prins and Scheltens 2015).”
BackgroundEarly changes in extracellular matrix in Alzheimer's disease
Lepelletier, F. ‐., Mann, D. M. A., Robinson, A. C., Pinteaux, E., & Boutin, H. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12295 · Cited by 198
Huppertz, H., Möller, L., Südmeyer, M., Hilker, R., Hattingen, E., Egger, K., Amtage, F., Respondek, G., Stamelou, M., Schnitzler, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26715 · Cited by 160
“14 15-17 In PSP, it could demonstrate reduced progression of brain atrophy in a randomized, placebo-controlled medication trial.”
BackgroundSelf-citationCohen, R. A., Seider, T. R., & Navia, B. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0123-4 · Cited by 149
“However, cortical changes in AD cases are typically more pronounced than in cases of HIV, and hippocampal atrophy occurs early and ubiquitously in AD whereas the hippocampus is not as vulnerable in HIV [62,63].”
BackgroundHippocampal atrophy based Alzheimer’s disease diagnosis via machine learning methods
Uysal, G., & Ozturk, M. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108669 · Cited by 133
“Frings et al. showed that decreasing of the temporal WM volume in patients with AD is faster than CN older people ’ s (Frings et al., 2014).”
Hedges, E. P., Dimitrov, M., Zahid, U., Vega, B. B., Si, S., Dickson, H., McGuire, P. K., Williams, S., Barker, G. J., & Kempton, M. J. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118751 · Cited by 134
Landin-Romero, R., Kumfor, F., Leyton, C. E., Irish, M., Hodges, J. R., & Piguet, O. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.03.032 · Cited by 116
“This study examined longitudinal neuroimaging changes in 14AD and 15 bvFTDpatients comparedwith 10 healthy controls (Frings et al., 2014).”
BackgroundSelf-citationAdvances in neuroimaging in frontotemporal dementia
Gordon, E., Rohrer, J. D., & Fox, N. C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13656 · Cited by 94
“…that increased annual atrophy in lateral orbitofrontal grey matter regions clearly differentiated bvFTD from both healthy controls and AD patients, whilst annual reductions in temporal lobe white matter structures were also important in classification of bvFTD subjects (Frings et al. 2014).”
BackgroundPanman, J. L., Jiskoot, L. C., Bouts, M. J. R. J., Meeter, L. H. H., van der Ende, E. L., Poos, J. M., Feis, R. A., Kievit, A. J. A., van Minkelen, R., Dopper, E. G. P., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.12.017 · Cited by 95
“On the other hand, previous research demonstrated that atrophy rates during the symptomatic stage of FTD are twice as high compared with patients with AD (Frings et al., 2014; Krueger et al., 2010; Whitwell, 2010), with the fastest atrophy rates in FTDGRN patients (Whitwell et al.”
ResultJiskoot, L. C., Panman, J. L., Meeter, L. H., Dopper, E. G. P., Donker Kaat, L., Franzen, S., van der Ende, E. L., van Minkelen, R., Rombouts, S. A. R. B., Papma, J. M., et al. (2019) · Brain · doi:10.1093/brain/awy288 · Cited by 91
“The small number of converters did not allow us to detect a robust sequential order of grey and white matter involvement or between specific cortical regions, while more extensive progression of white matter pathology than grey matter abnormalities were found in longitudinal studies in the symptomatic stage (Frings et…”
BackgroundInfluentialElahi, F. M., Marx, G., Cobigo, Y., Staffaroni, A. M., Kornak, J., Tosun, D., Boxer, A. L., Kramer, J. H., Miller, B. L., & Rosen, H. J. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.09.007 · Cited by 59
“To date, few studies have investigated longitudinal change in white matter integrity in FTD and AD (Frings et al., 2014; Zhang et al., 2016; Mahoney et al., 2015; Lam et al., 2014; Floeter et al., 2016; Tu et al., 2016), and only one prior study has generated sample size estimates, specifically in…”
Hafkemeijer, A., Möller, C., Dopper, E. G. P., Jiskoot, L. C., van den Berg-Huysmans, A. A., van Swieten, J. C., van der Flier, W. M., Vrenken, H., Pijnenburg, Y. A. L., Barkhof, F., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150695 · Cited by 57
Schönecker, S., Neuhofer, C. M., Otto, M., Ludolph, A. C., Kassubek, J., Landwehrmeyer, G. B., Anderl‐Straub, S., Semler, E., Diehl‐Schmid, J., Prix, C., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00045 · Cited by 62
“…in detail elsewhere (Huppertz et al., 2010, 2016; Opfer et al., 2016) and was already applied to neurodegenerative diseases in various cross-sectional and longitudinal studies (Kassubek et al., 2011; Frings et al., 2012, 2014; Höglinger et al., 2014; Huppertz et al., 2016; Schönecker et al., 2016).”
BackgroundSelf-citationLooking beneath the surface: the importance of subcortical structures in frontotemporal dementia
Bocchetta, M., Malpetti, M., Todd, E. G., Rowe, J. B., & Rohrer, J. D. (2021) · Brain Communications · doi:10.1093/braincomms/fcab158 · Cited by 62
“Volume loss is smaller in bvFTD, around 10–19% smaller than controls in one study, with an annual atrophy rate of 4%.(7,27,28)”
BackgroundFTD spectrum: Neuroimaging across the FTD spectrum
Whitwell, J. L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.05.009 · Cited by 53
Strikwerda-Brown, C., Ramanan, S., & Irish, M. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s158996 · Cited by 49
Möller, C., Hafkemeijer, A., Pijnenburg, Y. A. L., Rombouts, S. A. R. B., van der Grond, J., Dopper, E. G. P., Swieten, J. C. V., Versteeg, A., Steenwijk, M. D., Barkhof, F., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.020 · Cited by 54
“, 2007, 2008), whereas others studied a few predefined regions of interest (ROIs) (Barnes et al., 2007; Chan et al., 2001; Frings et al., 2014; Krueger et al., 2010) or included the full clinical spectrum of frontotemporal lobar degeneration (FTLD) with large variability in patterns of atrophy as a consequence (Barnes…”
InfluentialMcCarthy, J., Collins, D. L., & Ducharme, S. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.08.028 · Cited by 47
“Other studies reported low to moderate accuracy in classifying bvFTD from AD using a range of single metrics including DTI, GM concentration, volumetry, and surface displacements (Frings et al., 2014; Mahoney et al., 2014; Möller et al., 2016; Raamana et al., 2014; Wang et al., 2016).”
InfluentialBouts, M. J. R. J., Möller, C., Hafkemeijer, A., van Swieten, J. C., Dopper, E., van der Flier, W. M., Vrenken, H., Wink, A. M., Pijnenburg, Y. A. L., Scheltens, P., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170893 · Cited by 47
“Differences in the extent and location of gray matter (GM) and white matter (WM) atrophy have been recognized as important markers that distinguish each dementia-type [10–14].”
Liu, Z., Zhao, Y., Zhang, H., Chai, Q., Cui, Y., Diao, Y., Xiu, J., Sun, X., & Jiang, G. (2015) · Hypertension Research · doi:10.1038/hr.2015.135 · Cited by 49
Devenney, E. M., Ahmed, R. M., & Hodges, J. R. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00015-7 · Cited by 46
Self-citationVisuospatial dysfunction in Alzheimer's disease and behavioural variant frontotemporal dementia
Salimi, S., Irish, M., Foxe, D., Hodges, J. R., Piguet, O., & Burrell, J. R. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.04.019 · Cited by 40
Self-citationOpfer, R., Suppa, P., Kepp, T., Spies, L., Schippling, S., & Huppertz, H. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.12.031 · Cited by 41
“The method has already been applied to neurodegenerative diseases in both cross-sectional and longitudinal studies, demonstrating its sensitivity to detect volume changes within 6 month intervals [11,12,14,17].”
Self-citationBi, X.-A., Xu, Q., Luo, X., Sun, Q., & Wang, Z. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00340 · Cited by 41
The applause sign in frontotemporal lobar degeneration and related conditions
Schönecker, S., Hell, F., Bötzel, K., Wlasich, E., Ackl, N., Süßmair, C., Otto, M., Anderl‐Straub, S., Ludolph, A. C., Kassubek, J., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9134-y · Cited by 32
Self-citationXie, Y., Cui, Z., Zhang, Z., Sun, Y., Sheng, C., Li, K., Gong, G., Han, Y., & Jia, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150184 · Cited by 32
“Significant GMV reductions in the gyrus rectus have been observed in the brains of AD patients [51] but not in the brains of patients with early stage AD (i.”
BackgroundFeis, R. A., Bouts, M. J. R. J., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Schouten, T. M., de Vos, F., van der Grond, J., van Swieten, J. C., & Rombouts, S. A. R. B. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.07.014 · Cited by 29
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
Marino, S., Bonanno, L., Buono, V. L., Ciurleo, R., Corallo, F., Morabito, R., Chirico, G., Marra, A., & Bramanti, P. (2019) · Journal of International Medical Research · doi:10.1177/0300060519830830 · Cited by 28
Gautherot, M., Kuchcinski, G., Bordier, C., Sillaire, A. R., Delbeuck, X., Leroy, M., Leclerc, X., Pruvo, J., Pasquier, F., & Lopes, R. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.729635 · Cited by 31
“EOAD had lower GM volume, which was consistent with the fact that AD experienced a faster decrease in GM volume when compared to aging subjects (Frings et al., 2014).”
ResultMRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia
Manera, A. L., Dadar, M., Van Swieten, J. C., Borroni, B., Sanchez-Valle, R., Moreno, F., Laforce Jr, R., Graff, C., Synofzik, M., Galimberti, D., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324106 · Cited by 23
“to distinguish between bvFTD and Cognitively Normal Subjects (CNCs), Alzheimer Disease or other psychiatric and neurologic disorders on an individual level using MRI-based features.(9-17)”
Frontotemporal dementia. How to deal with its diagnostic complexity?
Antonioni, A., Raho, E. M., Granieri, E., & Koch, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461758 · Cited by 25
“Conversely, bvFTD patients exhibit more pronounced changes in the lateral orbitofrontal cortex, a relevant aspect for both identifying the disease subtype and differentiating it from AD [267,268].”
Termine, A., Fabrizio, C., Caltagirone, C., Petrosini, L., & Initiative, O. B. O. T. F. L. D. N. (2022) · Life · doi:10.3390/life12070947 · Cited by 30
“FTD patients included in this database are diagnosed with one of the following disease variants: behavioral variant, semantic variant, progressive non-fluent aphasia, progressive supranuclear palsy, or cortico-basal syndrome.”
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease
Littau, J. L., Velilla, L., Hase, Y., Villalba‐Moreno, N. D., Hagel, C., Drexler, D., Osorio Restrepo, S., Villegas, A., Lopera, F., Vargas, S., et al. (2022) · Brain Pathology · doi:10.1111/bpa.13097 · Cited by 20
“WMH of vascular origin, frequently used as the clinical signature for early detection and progression of SVD [15] are common in late-onset AD [16, 17] just as they are a key diagnostic feature of CADASIL.”
MethodThompson, R., Tong, X., Shen, X., Ran, J., Sun, S., Yao, X. I., & Shen, C. (2024) · Environment International · doi:10.1016/j.envint.2024.109219 · Cited by 20
Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers
Chen, Q., Boeve, B. F., Schwarz, C. G., Reid, R. I., Tosakulwong, N., Lesnick, T. G., Bove, J., Brannelly, P., Brushaber, D. E., Coppola, G., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.011 · Cited by 22
“Of the 22 MAPT mutation carriers at the baseline, 12 participants had no clinical symptoms and a CDR Dementia Staging Instrument plus NACC FTLD Behavior and Language Domains sum of boxes (CDR plus NACC FTLD-SB) (Knopman et al., 2008) of 0, which we refer to as asymptomatic MAPT mutation carriers.”
ResultInfluentialOhm, D. T., Kım, G., Gefen, T. D., RADEMAKER, A. W., Weıntraub, S., Bigio, E. H., Mesulam, M. M., Rogalski, E. J., & Geula, C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12494 · Cited by 23
Classification on Alzheimer’s Disease MRI Images with VGG-16 and VGG-19
Antony, F., Anita, H. B., & George, J. A. (2022) · Smart innovation, systems and technologies · doi:10.1007/978-981-19-3575-6_22 · Cited by 22
Feis, R. A., Bouts, M. J. R. J., Panman, J. L., Jiskoot, L. C., Dopper, E. G. P., Schouten, T. M., de Vos, F., van der Grond, J., Swieten, J. C. V., & Rombouts, S. A. R. B. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101718 · Cited by 20
A review of AI-based radiogenomics in neurodegenerative disease
Liu, H., Zhang, X., & Liu, Q. (2025) · Frontiers in Big Data · doi:10.3389/fdata.2025.1515341 · Cited by 17
McKenna, M. C., Murad, A. A., Huynh, W., Lope, J., & Bede, P. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2048648 · Cited by 16
“The involvement of the subcortical regions, specifically loss of GM volume in the caudate, resulted in an accuracy of 79% in differentiating bvFTD from AD [100].”
ResultKärkkäinen, M., Prakash, M., Zare, M., Tohka, J., & Initiative, A. D. N. (2020) · International Journal of Alzheimer s Disease · doi:10.1155/2020/2142854 · Cited by 21
“…manifest themselves as a wide array of Regarding AD and frontotemporal degeneration (FTD), the behavioral variant of FTD (bvFTD) was di ff erentiated from AD based on gray matter content in the nucleus cauda-tus and inferior frontal lobe adjacent to the longitudinal fi s-sure (gyrus rectus) in [27].”
Horvath, A. A., Szűcs, A., Barcs, G., Fabó, D., Kelemen, A., Halász, P., Erőss, L., & Kamondi, A. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170020 · Cited by 14
“, overlapping imaging findings and clinical syndrome [9].”
McKenna, M. C., Tahedl, M., Murad, A. A., Lope, J., Hardiman, O. M., Hutchinson, S., & Bede, P. (2022) · Brain and Behavior · doi:10.1002/brb3.2500 · Cited by 13
“(Bouts et al., 2018; Bron et al., 2017; Canu et al., 2017; Frings et al., 2014; Hu et al., 2020; Kim et al., 2019; Ma et al., 2020; Möller et al., 2016; Wang et al., 2016; Yu et al., 2021).”
Jih, K., Lai, K., Lin, K., Liao, Y., & Lee, Y. (2022) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000837 · Cited by 12
Jiskoot, L. C., Russell, L. L., Greaves, C. V., van Schaik, E., van den Berg, E., Poos, J. M., de Boer, L., Kaat, L. D., Seelaar, H., Pijnenburg, Y. A. L., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11596-3 · Cited by 11
Bruchhage, M. M. K., Correia, S., Malloy, P. F., Salloway, S., & Deoni, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.524024 · Cited by 12
Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia
Huang, M., Landín-Romero, R., Matis, S., Dalton, M. A., & Piguet, O. (2024) · Journal of Neurology · doi:10.1007/s00415-023-12172-5 · Cited by 11
Lok, H. C., & Kwok, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052541 · Cited by 12
“[26,66,67,68,69,70,71,72,73,74,75,76,77], suggesting a role for glial cells in the aetiology of”
BackgroundAlzheimer’s disease classification from hippocampal atrophy based on PCANet-BLS
Liang, C., Lao, H., Wei, T., & Zhang, X. (2022) · Multimedia Tools and Applications · doi:10.1007/s11042-022-12228-0 · Cited by 9
“The work in the literature [5, 14, 21] shows that we can use it as a good biomarker for the diagnosis of AD by observing the reduction in the volume of white matter (WM) in the MR images.”
Fieldhouse, J. L. P., van Paassen, D. N., van Engelen, M.-P. E., De Boer, S. C. M., Hartog, W. L., Braak, S., Schoonmade, L. J., Schouws, S. N. T. M., Krudop, W. A., Oudega, M. L., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1382593 · Cited by 8
Shalev, M. A., Pesce, M., Tilve, S. M., Chieregatti, E., Zalevsky, Z., & Difato, F. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.18.11.111415 · Cited by 7
Farina, M. P., Saenz, J. L., & Crimmins, E. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285220 · Cited by 6
Applied multimodal diagnostics in a case of presenile dementia
Schönecker, S., Brendel, M., Huber, M., Vollmar, C., Huppertz, H., Teipel, S. J., Okamura, N., Levin, J., Rominger, A., & Danek, A. (2016) · BMC Neurology · doi:10.1186/s12883-016-0647-7 · Cited by 5
“Volumetric MRI analysis however revealed significant atrophy of the parietal and temporal lobe, especially of the hippocampus, and may therefore be useful to obtain rater- independent and objective results [7, 8].”
BackgroundSelf-citationShirian, S., Tahmasebian, N., Moghadam, B. B., Kiani, F. Z., & Amini, M. R. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.12.3.103 · Cited by 4
MRI ‐ DTI Biomarkers Along the Continuum of Behavioral Variant Frontotemporal Dementia
Michelutti, M., Huppertz, H., Anderl‐Straub, S., Volkmann, H., Urso, D., Tafuri, B., Nigro, S. L., Manganotti, P., Rosenbohm, A., Ludolph, A. C., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70438 · Cited by 4
“A decoupling of the localization of longitudinal GM and WM changes, with WM alterations both preceding and exceeding GM in magnitude, has been described in symptomatic FTLD cases [19, 48, 50, 55].”
Self-citationKalaria, R. N., Hase, Y., & Ihara, M. (2019) · Future Neurology · doi:10.2217/fnl-2019-0004 · Cited by 3
GRN mutation in a patient with a behavioral variant of frontotemporal lobar degeneration (bvFTD)
Walczysková, S., Ressner, P., Hilscherová, Š., Kotlas, J., Konrád, J., & Svobodová, V. (2017) · Folia Neuropathologica · doi:10.5114/fn.2017.66715 · Cited by 2
Adhikari, R., Steed, K. S., Hutchinson, B., Wang, H., Mendoza, M., Staudte, R., Atmojo, M., Cox, P., Hancock, T., Barkdull, K., et al. (2020) · Brain and Nerves · doi:10.15761/jbn.1000127 · Cited by 2
“Currently, however, MRI is not a perfect tool for diagnosing AD, but it does allow visualization of neuroatrophy and other artifacts not normally observable until after autopsy [11-13].”
BackgroundAiello, E. N., Canu, E., Castelnovo, V., Frisco, F., Curti, B., Moreschi, A., Luca, G. D., Sibilla, E., Freri, F., Tripodi, C., et al. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14101-8 · Cited by 1
“…while AD also involves frontal regions, longitudinal data indicate that frontal atrophy in bvFTD progresses at a significantly higher rate in the orbitofrontal cortex [37] and shows a measurable increase in frontotemporal lobar degenerations even over a one-year interval [38] compared to AD.”
Morphometrische und volumetrische MRT-Auswertung
Huppertz, H. (2018) · Clinical Epileptology · doi:10.1007/s10309-017-0165-7 · Cited by 1
Self-citationBehavioral Variant Frontotemporal Dementia
Ford, J. N., & Chiang, G. C.-Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_26 · Cited by 2
MRI-Based Multi-Class Relevance Vector Machine Classification of Neurodegenerative DiseasesPreprint
Younes, K., Cobigo, Y., Wolf, A. A., Kornak, J., Rankin, K. P., Beg, M. F., Wang, L., & Rosen, H. J. (2024) · medRxiv · doi:10.1101/2024.10.07.24315054 · Cited by 3
“One practical limitation of many of these studies is the use of binary classification (e.g. distinction of AD from FTD) [11, 12, 13, ¨oller2016 ?”
BackgroundAlzheimer's Disease and Diabetes: A Transgenic Mouse Model in Behavior, MRI, and Cells
Steed, K. S. (2018) · ScholarsArchive (Brigham Young University)
Herzog, N. J., & Magoulas, G. D. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-20837-9_5
Classification of Brain Neuroimaging for Alzheimer's Disease Employing Principal Component Analysis
shehata, F. E., Makkey, M. Y., & Abdelrahman, S. A. (2024) · Menoufia Journal of Electronic Engineering Research · doi:10.21608/mjeer.2023.232914.1079
“According to [3-4], the white matter (WM) area of AD patients is much lower than that of cognitive normal (CN).”
BackgroundMicrostructural grey matter alterations in patients with behavioural variant frontotemporal dementia
Akbarian, B., Hett, K., Phan, T. X., Lee, J. J., Eaton, J. E., Donahue, M. J., & Darby, R. R. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf427
“11-23 However, brain volume measurements may lack the sensitivity to detect subtle structural changes that could precede frank volume loss.”
Görgülü, F. F., & Görgülü, O. (2026) · Medicina · doi:10.3390/medicina62081615
“Volume loss in the gyrus rectus and adjacent orbitofrontal cortex has also been described in dementia syndromes, and gray-matter loss in prefrontal and orbitofrontal regions has been linked to neuropsychiatric symptoms in AD [25,26].”
Metadata
- Authors
- Frings, L., Yew, B., Flanagan, E., Lam, B. Y. K., Hüll, M., Huppertz, H.-J., Hodges, J. R., & Hornberger, M.
- Affiliations
- University of Freiburg (DE)
- Neuroscience Research Australia (AU)
- UNSW Sydney (AU)
- Swiss Epilepsy Center (CH)
- Corresponding author
- Hornberger, Michael
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-03
- Volume
- 9
- Issue
- 3
- Pages
- e90814
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3940927
- OpenAlex
- W2034517662
- Cited by
- 69
- References
- 44
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 7 · 2020: 4 · 2019: 10 · 2018: 9 · 2017: 4 · 2016: 5 · 2015: 6
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pfizer
- Neuroscience Research Australia
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung (01GW0662)
- Medical Research Council
- Australian Research Council (DP110104202, FF0776229)
- National Health and Medical Research Council (FF0776229)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- behavioral variant frontotemporal dementia, Alzheimer's disease, gray matter atrophy, white matter atrophy, caudate nucleus, gyrus rectus, differential diagnosis of dementia, brain atrophy
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Australia, Brain, Diagnosis, Differential, Germany, Humans, Magnetic Resonance Imaging, Organ Size, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.